Arrowhead Pharmaceuticals Inc

NASDAQ: ARWR
$16.84
+$0.05 (+0.30%)
Closing Price on July 7, 2025

ARWR Stock Chart and Intraday Price

ARWR Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector TRADE & SERVICES
Industry SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Address 225 SOUTH LAKE AVENUE, SUITE 1050, PASADENA, CA, US
Fiscal Year End September
Latest Quarter 12/31/2023
Market Cap 4,470.20M USD
Shares Outstanding 123,897,000
Arrowhead Pharmaceuticals Inc is a pioneering biopharmaceutical company focused on developing innovative medicines for challenging diseases. With a robust pipeline, it targets conditions like hypertriglyceridemia, non-alcoholic steatohepatitis, and various pulmonary diseases, among others. Arrowhead is actively conducting clinical trials across different phases to combat diseases such as chronic hepatitis B, liver diseases, and alpha-1 antitrypsin deficiency-related liver disease. The company collaborates with industry giants like Janssen Pharmaceuticals and Amgen, showcasing its commitment to advancing healthcare. Founded in 2003 and based in Pasadena, California, Arrowhead is at the forefront of medical research.

ARWR Articles

Prediction: This Pharma Stock Will Be the Best Performer in 2025
Market pullbacks can make nervous investors leery of investing in industries that are more speculative. Wall Street still has big expectations for Viking Therapeutics.
Trey Thoelcke
Published:

Monday's Top Analyst Upgrades and Downgrades: Dish Network, EA, Fox, Gilead Sciences, Molson Coors, PacWest, SoFi, Twilio and More
Monday's top analyst upgrades and downgrades included CyberArk Software, Diageo, Dish Network, Electronic Arts, Fox, Gilead Sciences, Molson Coors Beverage, O’Reilly Automotive, PacWest Bancorp,...
Lee Jackson
Published:

Thursday's Top Analyst Upgrades and Downgrades: Albertsons, Alphabet, Apple, Coinbase, General Electric, McDonald's, Microsoft, Tesla and More
Thursday's top analyst upgrades and downgrades included Albertsons Companies, Alphabet, Apple, Coinbase Global, Danaher, Enphase Energy, GE HealthCare Technologies, General Electric, McDonald's,...
Lee Jackson
Published:

Wednesday's Top Analyst Upgrades and Downgrades: Delta Air Lines, Microchip Technology, Philip Morris, Pinduoduo, Shopify and More
Wednesday's top analyst upgrades and downgrades included APA, Delta Air Lines, Generac, Lululemon Athletica, Microchip Technology, Paccar, Philip Morris International, Pinduoduo, Shopify,...
Lee Jackson
Published:

Thursday's Top Analyst Upgrades and Downgrades: Boeing, Capital One, Coinbase, Electronic Arts, Harley-Davidson, Peloton, Walmart, Wynn Resorts and More
Thursday's top analyst upgrades and downgrades included Alcon, Array Technologies, AZEK, Boeing, Capital One Financial, Coinbase Global, Corning, Electronic Arts, Harley-Davidson, ON Semiconductor,...
Lee Jackson
Published:

Friday Afternoon Analyst Upgrades and Downgrades: Carnival, Duke Energy, Petco Health and More
24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Friday, including American Water Works, Carnival, Duke Energy, Okta and Zscaler.
Chris Lange
Published:

Biogen, Fortinet, Kohl's, Pinterest, Snap and More Friday Afternoon Analyst Calls
The Friday afternoon analyst calls were focused on Biogen, Fortinet, Pinterest, Snap and more.
Chris Lange
Published:
Last Updated:

Why This Interim Liver Study Is Huge for Arrowhead Pharma
Arrowhead Pharmaceuticals has announced positive interim 24-week liver biopsy results in four subjects from its midstage study of ARO-AAT. Shares rallied on the news early Wednesday. 
Chris Lange
Published:
Last Updated: